This federal contract award is for the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen, 3 mL) and was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $8,398.28 firm-fixed-price delivery order has a completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated as a set-aside contract. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) that specializes in distributing a wide array of medical commodities to federal agencies, particularly within the Department of Defense and Veterans Affairs healthcare systems.
Generated 3/16/25, 12:45 AM